Small-cap stocks delivered divergent catalysts this week. RELY.US (RELY.US) faced shareholder litigation after Q1 2026 revenue missed estimates by $4.78 million, triggering volatility. XPON.US (XPON.US) countered with momentum, presenting its Edge lithium-ion battery system at Noble Capital's June 12 conference to target oil and gas microgrids. Biotech players SRZN.US (SRZN.US) and BDTX.US (BDTX.US) advanced pipelines—SRZN published Wnt pathway research in eLife on June 12 while BDTX progressed MasterKey oncology therapies. AVT.US (AVT.US) strengthened AI commercialization through a June 7 partnership with the University of Hong Kong. GPAK.US (GPAK.US) expanded esports events in Pakistan, CCOI.US (CCOI.US) maintained global network infrastructure operations, and CORT.US (CORT.US) continued cortisol-focused drug development. New ETF AIQD.US (AIQD.US) drew attention as an AI-themed investment vehicle.